Shamonda Virus: First Human Death Reported as Kenyans Seek Clarity on Infection Risks

The World Health Organization (WHO) has reported the first documented human infection with Shamonda virus in France after an infected patient died, raising questions about the virus and its potential risks to human health.

WHO Director-General Tedros Adhanom Ghebreyesus announced the case on Thursday, October 22, 2026. He said the patient was immunocompromised, meaning their immune system was weakened and they were more vulnerable to infections and severe illness.

The circumstances surrounding the infection remain under investigation. French health authorities are working with the WHO to establish how the patient contracted the virus, whether it can spread between humans and what implications the case could have for public health.

Shamonda virus has previously been identified in animals, including cattle, sheep, goats and horses. Scientists first isolated it from cattle in Nigeria in 1965, and subsequent detections have been reported in parts of Africa and Asia. The virus belongs to the Orthobunyavirus genus and the Peribunyaviridae family.

The virus is associated with Culicoides midges, tiny insects that transmit infections among animals through their bites. Researchers are investigating the circumstances of the French case, including the possible route of transmission. The fact that the infection occurred in an area where the virus was circulating among animals and midges were present has become an important part of the investigation.

In animals, reported signs of infection include fever, diarrhoea and reduced milk production. Reproductive complications, including abortions and foetal abnormalities, have also been reported. Some horses have experienced neurological problems, although the full effects of the virus variants circulating in Europe remain uncertain.

For Kenyans, the reported death does not automatically mean there is an outbreak or an immediate public health threat in the country. The case is the first documented human infection, and more information is needed to establish the likelihood of human infection and the possible routes of transmission.

There is currently no commercially available vaccine specifically against Shamonda virus. According to animal health research, immunity to the related Schmallenberg virus may offer limited cross-protection, although the implications for Shamonda virus remain unclear.

Preventing exposure to infected midges remains an important control measure in affected animal settings. Measures include installing fine-mesh screens, reducing insect breeding sites, using appropriate repellents around livestock and monitoring insect activity near animal housing.

Kenya’s health and veterinary authorities would need to assess any evidence of local transmission before determining whether additional public health measures are necessary. Anyone concerned about unusual illness in livestock should seek advice from a veterinary professional, while suspected human illness should be assessed by a qualified healthcare provider.

Source: https://www.facebook.com/100046664565790/posts/1843292357236232/?app=fbl

OneNews feedback-opera-news-app@opera.com